Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' demand for sensitive information.
The decision became public after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "skewed".
An official spokesperson has since explained that the US was requesting biological samples for research and commercial gain but was not willing to share the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to secure a deal agreeable to all parties so the country's critical HIV programme can proceed.
Wider Implications
This development comes after a similar case in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and accountability.
Based on reports, 16 African countries have to date agreed to similar health pacts, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," he stated.
"Effectively, our nation would supply the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our population should a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures previously established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how future collaboration might be structured in a manner that honours the independence and dignity of both nations."
Medical Community Response
Medical experts stated it understood the government's concerns, but recommended that negotiations must proceed since much of the nation's Aids initiatives depended on foreign aid.
"Where specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group commented.
The situation underscores the complex challenges between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.